← FDA Drug Approvals (Drugs@FDA)
DOXEPIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ADAPTIS · Approved 2022-04-19
Drug application
- FDA Application #
ANDA213796- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOXEPIN HYDROCHLORIDE
- Generic name
- Doxepin Hydrochloride
- Active ingredients
- DOXEPIN HYDROCHLORIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ADAPTIS
- First approval
- 2022-04-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown